Department of Neurology

January 24, 2023

How arterial “stiffness” may impair cognition

New findings from Vanderbilt neurologists suggest that cardiovascular disease may increase the spaces surrounding blood vessels in the brain and lead to cognitive decline.

January 6, 2023

Early effects of Huntington disease

Impairments in brain executive function happen earlier than motor symptoms in people with the gene mutation that causes Huntington disease, suggesting younger ages and cognitive symptoms be considered for any future clinical trials.

The certification team included, from left, Arlene Boudreaux, MSN, RN, CNRN, Ryan Schell, PharmD, BCPS, Fenna Phibbs, MD, MPH, and Jessica Stroh, RN. (photo by Donn Jones)
December 1, 2022

VUMC receives national certification for Parkinson’s disease care

Vanderbilt University Medical Center recently became the nation’s second health care organization to receive The Joint Commission’s Gold Seal of Approval for Parkinson’s Disease Certification.

November 17, 2022

Study examines impulsiveness in Parkinson’s disease

Vanderbilt researchers are studying aspects of dopamine release and its regulation in Parkinson’s patients with and without impulsive-compulsive behaviors.

November 10, 2022

Kennedy Center seeks participants for disabilities research learning sessions

In January, a series of online learning sessions hosted by Vanderbilt Kennedy Center will bring together stakeholders who wish to see research advance toward understanding and solving the health problems that tend to affect adults with IDD.

November 8, 2022

Alzheimer’s risk factor and cognition

Vanderbilt researchers found that a protein with roles in innate immunity worsens memory at baseline in carriers of APOE-e4, the strongest genetic risk factor for Alzheimer’s disease, further implicating neuroinflammation in cognitive decline.